Boston Scientific Corp BSX

NYSE US Health Care

$43.88 ▼ -0.52% ($-0.23)

Index member: S&P 500

Open $44.15

Prev Close $44.11

Day Range $43.22 – $44.30

52W Range $42.20 – $105.65

Market Cap $64.75B

P/E (TTM) 17.15

Beta 0.60

EPS (TTM) $2.47

📋 Company Profile

Industry	Health Care
Country	US
Exchange	NEW YORK STOCK EXCHANGE, INC.
Currency	USD
IPO Date	1992-05-19
Shares Out.	1,486,360,000
Website	bostonscientific.com/en-US/Home.html ↗
Phone	13026365400
Employees	59,000
Revenue	$5.44B
Gross Profit	$3.85B
Net Income	$905.0M
Free Cash Flow	$3.62B
Total Assets	$45.22B
Total Liabilities	$20.04B
Equity	$25.17B

About Boston Scientific Corp

Boston Scientific focuses on less invasive medical devices that are inserted into the human body through small openings or cuts. It manufactures products for use in angioplasty, blood clot filtration, kidney stone management, cardiac rhythm management, catheter-directed ultrasound imaging, upper gastrointestinal tract diagnostics, interventional oncology, neuromodulation for chronic pain, and treatment of incontinence. The firm markets its devices to healthcare professionals and institutions globally. Foreign sales account for roughly 36% of the firm's total sales.

Boston Scientific Corp is a publicly traded company under the ticker symbol BSX on the NEW YORK STOCK EXCHANGE, INC., operating in the Health Care industry. Quotes and metrics shown here are sourced from public market data and refreshed regularly.